TP53 and cancer: Together with the clinical observation of an LFS-characteristic tumor in a patient with a germline p53 T253I mutation, our studies suggest that p53 T253I results in a loss of p53 function and may establish a pro-carcinogenic cellular state consistent with a cancer predisposition syndrome such as LFS.